AXINLOW SIGNALFINANCIAL10-Q

AXIN's Q3 filing shows routine SPAC operations with modest quarterly losses and stable trust account value appreciation.

As a recently public SPAC, AXIN continues its search for a business combination target without having entered definitive agreements as of September 30, 2025. The trust account value has grown to $10.11 per share from the initial $10.00, providing modest returns for potential redemptions.

Comparing 2025-11-13 vs 2025-08-12View on EDGAR →
FINANCIAL ANALYSIS

The company's financial position reflects typical early-stage SPAC operations, with operating losses expanding modestly due to ongoing search costs and professional fees. Current liabilities nearly doubled largely due to accrued expenses, while current assets declined slightly. Net income remained positive at $1.5M despite operating losses, benefited by trust account investment returns, though this decreased from the prior quarter's $1.9M.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+89.3%
$105K→$198K

Current liabilities surged 89.3% — significant near-term obligations; verify ability to meet short-term debt.

Operating Income
P&L
-48.3%
-$185K→-$275K

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-19.9%
$1.9M→$1.5M

Net income declined 19.9% — review whether driven by operations, interest costs, or non-recurring items.

Current Assets
Balance Sheet
-17.8%
$872K→$717K

Current assets declined 17.8% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2025-11-13
PRIOR — 2025-08-12
ADDED
4 AXIOM INTELLIGENCE ACQUISITION CORP 1 NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2025 NOTE 1.
As of September 30, 2025, the Company had not entered into a definitive agreement with any specific Business Combination target.
As of September 30, 2025, the Company had not commenced any operations.
5 AXIOM INTELLIGENCE ACQUISITION CORP 1 NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2025 Following the closing of the Initial Public Offering, on June 20, 2025, an amount of $ 200,000,000 ($ 10.00 per Unit) from the net proceeds of the Initial Public Offering and the Private Placement was placed in a trust account (the Trust Account ), with Continental Stock Transfer Trust Company ( Continental ), acting as trustee.
The Company will provide the Public Shareholders (excluding the Sponsor, officers and directors to the extent they acquire Public Shares) with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer.
+7 more — sign up free →
REMOVED
4 AXIOM INTELLIGENCE ACQUISITION CORP 1 NOTES TO CONDENSED FINANCIAL STATEMENTS JUNE 30, 2025 (UNAUDITED) NOTE 1.
As of June 30, 2025, the Company had not selected any specific Business Combination target.
As of June 30, 2025, the Company had not commenced any operations.
Following the closing of the Initial Public Offering, on June 20, 2025, an amount of $ 200,000,000 ($ 10.00 per Unit) from the net proceeds of the Initial Public Offering and the Private Placement was placed in a trust account (the Trust Account ), with Continental Stock Transfer Trust Company ( Continental ), acting as trustee.
5 AXIOM INTELLIGENCE ACQUISITION CORP 1 NOTES TO CONDENSED FINANCIAL STATEMENTS JUNE 30, 2025 (UNAUDITED) The Company will provide the Public Shareholders (excluding the Sponsor, officers and directors to the extent they acquire Public Shares) with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →